References
- CDC. What is ADHD? [Internet]. Centers for Disease Control and Prevention; 2020 [cited 2020 Sep 9]. Available from: https://www.cdc.gov/ncbddd/adhd/facts.html
- Attention-deficit/hyperactivity disorder (ADHD) in children - Symptoms and causes [Internet]. Mayo Clinic. [cited 2020 Dec 28]. Available from: https://www.mayoclinic.org/diseases-conditions/adhd/symptoms-causes/syc-20350889
- Visser SN, Danielson ML, Bitsko RH, et al. Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011. J Am Acad Child Adolesc Psychiatry. 2014;53:34–46.e2.
- Barbaresi WJ, Colligan RC, Weaver AL, et al. Mortality, ADHD, and psychosocial adversity in adults with childhood ADHD: a prospective study. Pediatrics. 2013;131:637–644.
- Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163:716–723.
- Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593–602.
- Montejano L, Sasané R, Hodgkins P, et al. Adult ADHD: prevalence of diagnosis in a US population with employer health insurance. Curr Med Res Opin. 2011;27:5–11.
- Chung W, Jiang S-F, Paksarian D, et al. Trends in the prevalence and incidence of Attention-Deficit/Hyperactivity Disorder among adults and children of different racial and ethnic groups. JAMA Network Open. 2019;2:e1914344.
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders [Internet]. Fifth ed. Arlington, Virginia: American Psychiatric Association; 2013. [cited 2020 Dec 28]. Available from: https://psychiatryonline.org/doi/book/10.1176/appi.books.9780890425596
- Young JL, Goodman DW. Adult Attention-Deficit/Hyperactivity Disorder diagnosis, management, and treatment in the DSM-5 era. Prim Care Companion CNS Disord. 2016;18. DOI:10.4088/PCC.16r02000
- Medical expenditure panel survey background [Internet]. [cited 2021 Jan 20]. Available from: https://www.meps.ahrq.gov/mepsweb/about_meps/survey_back.jsp
- Hill SC, Zuvekas SH, Zodet MW. Implications of the accuracy of MEPS prescription drug data for health services research. Inquiry. 2011;48:242–259.
- Machlin S, Yu W, Zodet M. Computing Standard Errors for MEPS Estimates [Internet]. Rockville (MD): Agency for Healthcare Research and Quality; 2005. [Internet]. [cited 2021 Jan 20]: http://www.meps.ahrq.gov/survey_comp/standard_errors.jsp
- Gupte-Singh K, Singh RR, Lawson KA. Economic burden of attention-deficit/hyperactivity disorder among pediatric patients in the United States. Value Health. 2017;20:602–609.
- May 2019 National Occupational Employment and wage estimates [Internet]. [cited 2020 Nov 24]. Available from: https://www.bls.gov/oes/currenT/oes_nat.htm#00-0000
- U.S. Department of Health and Human Services. National Health Expenditure Accounts: methodology paper, 2019; 2019. 44.
- Coughlan D, Yeh ST, O’Neill C, et al. Evaluating direct medical expenditures estimation methods of adults using the medical expenditure panel survey: an example focusing on head and neck cancer. Value Health. 2014;17:90–97.
- Precision standards guidelines for reporting MEPS-HC descriptive statistics [Internet]. [cited 2020 Dec 11]. Available from: https://meps.ahrq.gov/survey_comp/precision_guidelines.shtml
- Park RE. Estimation with Heteroscedastic Error Terms. Econometrica. 1966;34:888.
- Deb P, Norton EC, Manning WG. Health econometrics using Stata. College Station (TX): Stata Press; 2017.
- Deb P, Norton EC. Modeling health care expenditures and use. Annu Rev Public Health. 2018;39:489–505.
- Belotti F, Deb P, Manning WG, et al. Twopm: two-part models. Stata J. 2015;15:3–20.
- Johnson DR, Young R. Toward best practices in analyzing datasets with missing data: comparisons and recommendations. J Marriage Family. 2011;73:926–945.
- White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30:377–399.
- Lee KJ, Carlin JB. Multiple imputation for missing data: fully conditional specification versus multivariate normal imputation. Am J Epidemiol. 2010;171:624–632.
- Demirtas H, Freels SA, Yucel RM. Plausibility of multivariate normality assumption when multiply imputing non-Gaussian continuous outcomes: a simulation assessment. J Stat Comput Simul. 2008;78:69–84.
- Enders CK. Applied missing data analysis. New York & London: Guilford Press; 2010.
- Multiple imputation in SAS Part 1 [Internet]. [cited 2021 Jul 22]. Available from: https://stats.idre.ucla.edu/sas/seminars/multiple-imputation-in-sas/mi_new_1
- SAS 9.4 Software [Internet]. [cited 2019 Oct 31]. Available from: https://www.sas.com/en_us/software/sas9.html
- StataCorp. Stata statistical software: release 16. College Station (TX): StataCorp LLC; 2019.
- Secnik K, Swensen A, Lage MJ. Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder. Pharmacoeconomics. 2005;23:93–102.
- Hodgkins P, Montejano L, Sasané R, et al. Cost of illness and comorbidities in adults diagnosed with attention-deficit/hyperactivity disorder: a retrospective analysis. Prim Care Companion CNS Disord. 2011;13:e1–e12.
- Berndt ER, Mortimer R, Bhattacharjya A, et al. Authorized generic drugs, price competition, and consumers’ welfare. Health Affairs. 2007;26:790–799.
- Dave CV, Hartzema A, Kesselheim AS. Prices of generic drugs associated with numbers of manufacturers. N Engl J Med. 2017;377:2597–2598.
- Voelker R. Generic ADHD drug. JAMA. 2017;318:232.
- Antshel KM, Hargrave TM, Simonescu M, et al. Advances in understanding and treating ADHD. BMC Med. 2011;9:72.
- Vangipuram Suresh K, Wang K, Margalit A, et al. Trends in out-of-pocket healthcare expenses before and after passage of the patient protection and affordable care act. JAMA Network Open. 2021;4:e215499.
- Liu C, Tsugawa Y, Weiser TG, et al. Association of the US affordable care act with out-of-pocket spending and catastrophic health expenditures among adult patients with traumatic injury. JAMA Network Open. 2020;3:e200157.
- Nowak SA, Eibner C, Adamson DM, et al. Effects of the affordable care act on consumer health care spending and risk of catastrophic health costs. Rand Health Q. 2014;3:3.
- Manchikanti L, Helm Ii S, Benyamin RM, et al. A critical analysis of obamacare: affordable care or insurance for many and coverage for few? Pain Physician. 2017;20:111–138.